USE OF PROLYL HYDROXYLASE INHIBITORS TO INDUCE HIF-RELATED METABOLIC CHANGES AND INCREASE C-KIT EXPRESSION IN CARDIOSPHERE-DERIVED CELLS

USE OF PROLYL HYDROXYLASE INHIBITORS TO INDUCE HIF-RELATED METABOLIC CHANGES AND INCREASE C-KIT EXPRESSION IN CARDIOSPHERE-DERIVED CELLS

Bibliographic Details
Main Authors:	Tan, S, Yeoh, K, Carr, C, Heather, L, Ambrose, L, Tan, J, Schofield, C, Clarke, K
Format:	Conference item
Published:	2011

Similar Items

Preconditioning of cardiosphere-derived cells With hypoxia or prolyl-4-hydroxylase inhibitors increases stemness and decreases reliance on oxidative metabolism
by: Tan, S, et al.
Published: (2015)

Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors.
by: Tan, S, et al.
Published: (2012)

Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors
by: Tan, S, et al.
Published: (2011)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
by: Mole, D, et al.
Published: (2003)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
by: Schlemminger, I, et al.
Published: (2003)

Regulation of HIF: prolyl hydroxylases.
by: Stolze, I, et al.
Published: (2006)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
by: Yeh, TL, et al.
Published: (2017)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
by: McNeill, L, et al.
Published: (2002)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
by: Yeoh, K, et al.
Published: (2013)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
by: Flashman, E, et al.
Published: (2010)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
by: Mayer, M, et al.
Published: (2018)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
by: Tuckerman, JR, et al.
Published: (2004)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
by: Chen, R, et al.
Published: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
by: Chen, R, et al.
Published: (2014)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
by: Cockman, M, et al.
Published: (2019)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
by: Holt-Martyn, JP, et al.
Published: (2019)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
by: Chan, M, et al.
Published: (2016)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
by: Chowdhury, R, et al.
Published: (2016)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
by: Chowdhury, R, et al.
Published: (2013)

Ethyl 2-(2,3-dihyroxybenzamido) ccetate induces hypoxia induced factor-related metabolic changes in cardiosphere-derived cells for myocardial infarction therapy
by: Schofield, C, et al.
Published: (2016)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
by: Singh, A, et al.
Published: (2020)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

HYPOXIC PRECONDITIONING OF CARDIOSPHERE-DERIVED CELLS TO INCREASE RETENTION IN THE INFARCTED HEART
by: Tan, S, et al.
Published: (2010)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
by: Lippl, K
Published: (2018)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
by: Wijeyekoon, JB
Published: (2013)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
by: Holt-Martyn, J, et al.
Published: (2019)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
by: Astuti, D, et al.
Published: (2010)

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia
by: Lawson, H, et al.
Published: (2024)

Inhibition of a viral prolyl hydroxylase
by: Langley, G, et al.
Published: (2019)

Oxygen sensing by HIF hydroxylases.
by: Schofield, C, et al.
Published: (2004)

Signalling hypoxia by HIF hydroxylases.
by: Schofield, C, et al.
Published: (2005)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
by: Masson, N, et al.
Published: (2003)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
by: Masson, N, et al.
Published: (2004)

Kinetic investigations of the oxygen entry pathway of the hypoxia-inducible factor (HIF) prolyl hydroxylase 2
by: Kearney, L
Published: (2015)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
by: Willam, C, et al.
Published: (2006)

Synthesis And Characterization Of Potential Human Hypoxia Inducible Factor (Hif) Prolyl Hydroxylase Domain 2 (Phd-2) Inhibitors
by: Toh, Lee Roy
Published: (2021)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
by: Lippl, K, et al.
Published: (2015)

Prolyl hydroxylases and therapeutics.
by: Smith, T, et al.
Published: (2010)

Therapeutic manipulation of the HIF hydroxylases.
by: Nagel, S, et al.
Published: (2010)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
by: Tian, Y, et al.
Published: (2006)